A meta-analysis that evaluated the results of 76 clinical trials suggests that GLP-1 medications, including Rybelsus, are linked to an increased risk of biliary and gallbladder diseases, inflammation of the gallbladder, and gallstones
What to Expect After Your Consultation After approval, understanding the process from prescription to delivery helps you prepare for starting treatment
Understanding the diverse roles of peptides helps us appreciate their potential in optimizing body composition and overall health
The clinical evolution of diabetes treatment also plays a role
Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids
Gallbladder disease, modest heart rate increases, and theoretical pancreatitis risk are safety considerations consistent with the incretin receptor agonist class